Efficient synthesis of N-acylbenzotriazoles using tosyl chloride: en route to suberoylanilide hydroxamic acid (SAHA)

Efficient synthesis of N-acylbenzotriazoles using tosyl chloride: en route to suberoylanilide hydroxamic acid (SAHA)

Bibliographic Details
Main Authors:	Khalid A. Agha, Nader E. Abo-Dya, Tarek S. Ibrahim, Eatedal H. Abdel-Aal
Format:	Article
Language:	English
Published:	Arkat USA, Inc. 2016-03-01
Series:	ARKIVOC
Online Access:	https://www.arkat-usa.org/arkivoc-journal/browse-arkivoc/ark.5550190.p009.459

Similar Items

Suberoylanilide Hydroxamic Acid (SAHA) Reduces Glutamate-Induced Oxidative Stress in Hippocampal Cells
by: Caner Günaydin, et al.
Published: (2022-07-01)

Suberoylanilide Hydroxamic Acid (SAHA) Is a Driver Molecule of Neuroplasticity: Implication for Neurological Diseases
by: Lucia Verrillo, et al.
Published: (2023-08-01)

In silico modification of suberoylanilide hydroxamic acid (SAHA) as potential inhibitor for class II histone deacetylase (HDAC)
by: Tambunan Usman SF, et al.
Published: (2011-11-01)

The anti-tumor effects and molecular mechanisms of suberoylanilide hydroxamic acid (SAHA) on the aggressive phenotypes of ovarian carcinoma cells.
by: Shuo Chen, et al.
Published: (2013-01-01)

Suberoylanilide Hydroxamic Acid (SAHA) Treatment Reveals Crosstalk Among Proteome, Phosphoproteome, and Acetylome in Nasopharyngeal Carcinoma Cells
by: Huichao Huang, et al.
Published: (2022-05-01)

Transcriptional profiling of suberoylanilide hydroxamic acid (SAHA) regulated genes in mineralizing dental pulp cells at early and late time points
by: Henry F. Duncan, et al.
Published: (2015-09-01)

Effects of treatment with suppressive combination antiretroviral drug therapy and the histone deacetylase inhibitor suberoylanilide hydroxamic acid; (SAHA) on SIV-infected Chinese rhesus macaques.
by: Binhua Ling, et al.
Published: (2014-01-01)

Comparative evaluation of the treatment efficacy of suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer cell lines and primary ovarian cancer cells from patients
by: Belau Antje, et al.
Published: (2006-07-01)

ING5‐mediated antineuroblastoma effects of suberoylanilide hydroxamic acid
by: Ji‐cheng Wu, et al.
Published: (2018-09-01)

In vivo inhibitory effect of suberoylanilide hydroxamic acid combined with sorafenib on human hepatocellular carcinoma cells
by: Dalin Hao, et al.
Published: (2020-03-01)

Suberoylanilide hydroxamic acid attenuates cognitive impairment in offspring caused by maternal surgery during mid-pregnancy.
by: Yunlin Feng, et al.
Published: (2024-01-01)

The histone deacetylase inhibitor suberoylanilide hydroxamic acid attenuates human astrocyte neurotoxicity induced by interferon-γ
by: Hashioka Sadayuki, et al.
Published: (2012-05-01)

Suberoylanilide Hydroxamic Acid, A Histone Deacetylase Inhibitor, Attenuates Postoperative Cognitive Dysfunction in Aging Mice
by: Min eJia, et al.
Published: (2015-09-01)

Multimodal nanoparticle‐containing modified suberoylanilide hydroxamic acid polymer conjugates to mitigate immune dysfunction in severe inflammation
by: Nhu Truong, et al.
Published: (2024-01-01)

Suberoylanilide Hydroxamic Acid Analogs with Heteroaryl Amide Group and Different Chain Length: Synthesis and Effect on Histone Deacetylase
by: Gabriele Micheletti, et al.
Published: (2024-01-01)

Combination of suberoylanilide hydroxamic acid with heavy ion therapy shows promising effects in infantile sarcoma cell lines
by: Kulozik Andreas E, et al.
Published: (2011-09-01)

The preparation of N-acylbenzotriazoles from aldehydes
by: Alan R. Katritzky, et al.
Published: (2003-10-01)

Adjuvant Epigenetic Therapy of Decitabine and Suberoylanilide Hydroxamic Acid Exerts Anti-Neoplastic Effects in Acute Myeloid Leukemia Cells
by: Sonia Abou Najem, et al.
Published: (2019-11-01)

Mid-gestational exposure to histone deacetylase inhibitor suberoylanilide hydroxamic acid influence cortical interneuron and astrocyte in mouse brain
by: Nunung Yuniarti, et al.
Published: (2017-06-01)

Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, enhances radiosensitivity and suppresses lung metastasis in breast cancer in vitro and in vivo.
by: Hui-Wen Chiu, et al.
Published: (2013-01-01)

Treatment of Alcohols with Tosyl Chloride Does Not always Lead to the Formation of Tosylates
by: Chuanmin Qi, et al.
Published: (2011-07-01)

Novel Sunifiram-carbamate hybrids as potential dual acetylcholinesterase inhibitor and NMDAR co-agonist: simulation-guided analogue design and pharmacological screening
by: Khalid A. Agha, et al.
Published: (2022-12-01)

Suberoylanilide hydroxamic acid suppresses hepatic stellate cells activation by HMGB1 dependent reduction of NF-κB1
by: Wenwen Wang, et al.
Published: (2015-11-01)

In vivo efficacy of the histone deacetylase inhibitor suberoylanilide hydroxamic acid in combination with radiotherapy in a malignant rhabdoid tumor mouse model
by: Thiemann Markus, et al.
Published: (2012-03-01)

Synthetic Utility of <i>N</i>-Acylbenzotriazoles
by: Mangal S. Yadav, et al.
Published: (2023-09-01)

N-Acylation of sulfonamides using N-acylbenzotriazoles
by: Alan R. Katritzky, et al.
Published: (2004-07-01)

Unexpected reactions of organozinc reagents with N-acylbenzotriazoles
by: Alan R. Katritzky, et al.
Published: (2002-02-01)

A new methodology for the synthesis of N-acylbenzotriazoles
by: Anoop S. Singh, et al.
Published: (2017-07-01)

Suberoylanilide hydroxamic acid induces hypersensitivity to radiation therapy in acute myelogenous leukemia cells expressing constitutively active FLT3 mutants.
by: Xufeng Chen, et al.
Published: (2013-01-01)

Trichloroacetimidate-Triggered Expeditious and Novel Synthesis of N-Acylbenzotriazoles
by: Mangal S. Yadav, et al.
Published: (2021-10-01)

Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Improves Energetic Status and Cardiomyogenic Differentiation of Human Dilated Myocardium-Derived Primary Mesenchymal Cells
by: Rokas Miksiunas, et al.
Published: (2020-07-01)

Discovery of Primarolides A and B from Marine Fungus <i>Asteromyces cruciatus</i> Using Osmotic Stress and Treatment with Suberoylanilide Hydroxamic Acid
by: Hope A. Igboeli, et al.
Published: (2019-07-01)

Evaluation of the efficacy of valproic acid and suberoylanilide hydroxamic acid (vorinostat) in enhancing the effects of first-line tuberculosis drugs against intracellular Mycobacterium tuberculosis
by: Martin Rao, et al.
Published: (2018-04-01)

Histone deacetylase inhibition by suberoylanilide hydroxamic acid during reperfusion promotes multifaceted brain and vascular protection in spontaneously hypertensive rats with transient ischaemic stroke
by: Andrea Díaz-Pérez, et al.
Published: (2024-03-01)

Suberoylanilide hydroxamic acid enhances the radiosensitivity of lung cancer cells through acetylated wild-type and mutant p53-dependent modulation of mitochondrial apoptosis
by: Kan Wu, et al.
Published: (2021-02-01)

Suberoylanilide hydroxamic acid overcomes erlotinib-acquired resistance via phosphatase and tensin homolog deleted on chromosome 10-mediated apoptosis in non-small cell lung cancer
by: Peng-Fei Wu, et al.
Published: (2020-06-01)

Room-temperature Suzuki–Miyaura coupling of heteroaryl chlorides and tosylates
by: Yang, Junfeng, et al.
Published: (2013)

1,3,4-Oxadiazoles from functionalized N-acylbenzotriazoles and acyl hydrazides
by: Alan R. Katritzky, et al.
Published: (2008-04-01)

First person – Santu Saha
Published: (2023-05-01)

Professor Kshitish Chandra Saha
by: Arijit Coondoo
Published: (2016-01-01)